| I-094 Vito Dozio Population PK and exposure-response modeling to support the design of trials with Debio 0123, a WEE1 inhibitor, in cancer patients Wednesday 10:20-11:50 |
| I-094 Vito Dozio Population PK and exposure-response modeling to support the design of trials with Debio 0123, a WEE1 inhibitor, in cancer patients Wednesday 10:20-11:50 |